Samir Tari

2.2k citations
24 papers · 1.4k · 2 hit papers · h-index 10

Impact in

  • Ophthalmology top 0.5%
    • Ocular Diseases and Behçet’s Syndrome
    • Retinal and Optic Conditions
    • Retinal Diseases and Treatments
    • Glaucoma and retinal disorders
    • Systemic Lupus Erythematosus Research

Papers in

    • Retinal Diseases and Treatments 11
    • Ocular Diseases and Behçet’s Syndrome 11
    • Retinal and Optic Conditions 8
    • Glaucoma and retinal disorders 4
    • Systemic Lupus Erythematosus Research 5

Samir Tari

23 papers receiving 1.3k citations

Samir Tari's Hit Papers

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial 2016 · 331 citations
3310+3+6Years since publication100200300400

Peers

Samir Tari
Comparison fields: 5 of 70
  • Ophthalmology 1.1k
  • Rheumatology 390
  • Clinical Biochemistry 166
  • Neurology 56
  • Hematology 72
Replace Marina Mesquida with:
Marina Mesquida Spain
Ryoji Yamakawa Japan
Rossella Franceschini Italy
June-Gone Kim South Korea
Xiongze Zhang China
Levent Akduman United States
Carol Wallace United Kingdom
Ioannis Vergados Greece
Rafael S. Grajewski Germany
L Broersma Netherlands
Samir Tari relative to Marina Mesquida Spain Marina Mesquida's profile →
Citations per field
00.5×9.2×
Marina Mesquida · 1×
Citations per year

Countries citing papers authored by Samir Tari

Since Specialization
Citations

This map shows the geographic impact of Samir Tari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Tari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Tari more than expected).

Fields of papers citing papers by Samir Tari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir Tari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Tari. The network helps show where Samir Tari may publish in the future.

Co-authors

The 25 scholars most cited alongside Samir Tari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Samir Tari Line = papers co-authored together Samir Tari links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Adalimumab in Patients with Active Noninfectious Uveitis
Hit paper breakdown →
2016418
2
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
2016331
3 2016172
4 2005157
5 200676
6 201754
7 200745
8 201728
9 200517
10 200615
11 20156
12
Comparison of 1-periodontal indices and cultural porphyromonas gingivalis colony count in aggressive periodontitis patients treated by scaling and rootplanning with or without metronidazole gel.
20126
13
Comparison of 1-Periodontal Indices and Cultural Porphyromonas Gingivalis Colony Count in Aggressive Periodontitis Patients Treated by Scaling and Rootplanning with or Without Metronidazole Gel
20124
14
Adalimumab in Patients With Active, Non-infectious Uveitis Requiring High-dose Corticosteroids: the VISUAL-1 Trial
20154
15 20134
16 20174
17 20163
18
Effect of adalimumab on visual functioning (VFQ-25) in VISUAL-1 trial patients with non-anterior non-infectious uveitis
20152
19
Retinal Function Assessment Following Intravitreal Injection of Erythropoietin in Rats: A Dose–Toxicity Study
20061
20
Reproducibility of Eye Movement Compensated Fundus Perimetry
20051

About Samir Tari

Samir Tari is a scholar working on Ophthalmology, Rheumatology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 24 papers that have together received 1.4k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (11 papers), Ocular Diseases and Behçet’s Syndrome (11 papers), Retinal and Optic Conditions (8 papers), Systemic Lupus Erythematosus Research (5 papers), Glaucoma and retinal disorders (4 papers), Retinal and Macular Surgery (3 papers), Retinal Imaging and Analysis (2 papers) and Oral microbiology and periodontitis research (2 papers). The work is most often cited by research in Ophthalmology (1.1k citations), Rheumatology (390 citations), Clinical Biochemistry (166 citations), Neurology (56 citations) and Hematology (72 citations). Samir Tari has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jennifer E. Thorne, Andrew D. Dick, Eric B. Suhler, Anne Camez, Martina Kron, Alexandra Song, Glenn J. Jaffe, Antoine P. Brézin, Nisha V. Kwatra and Martha Skup. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Annals of the Rheumatic Diseases, JAMA Ophthalmology, Ophthalmic Epidemiology and Experimental Eye Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact